References
Byrne MJ, Power JM, Preovolos A, Mariani JA, Hajjar RJ, Kaye DM . Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Therapy 2008; 15: 1550–1557.
Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar R et al. Percutaneous cardiac recirculation-mediated gene transfer o of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 2007; 50: 253–260.
Bridges CR, Burkman JM, Malekan R, Konig SK, Chen H, Yarnall CB et al. Global cardiac-specific transgene expression using cardio-pulmonary bypass with cardiac isolation. Ann Thorac Surg 2002; 73: 1939–1946.
Bridges CR, Gopal K, Holt DE, Yarnall C, Cole S, Anderson RB et al. Efficient myocyte gene delivery using complete cardiac surgical isolation in situ. J Thorac Cardiovasc Surg 2005; 130: 1364–1370.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bridges, C. ‘Recirculating cardiac delivery’ method of gene delivery should be called ‘non-recirculating’ method. Gene Ther 16, 939–940 (2009). https://doi.org/10.1038/gt.2009.35
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2009.35
- Springer Nature Limited
This article is cited by
-
Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction
Gene Therapy (2016)
-
Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection
Journal of Translational Medicine (2014)
-
Percutaneous Approaches for Efficient Cardiac Gene Delivery
Journal of Cardiovascular Translational Research (2013)
-
Gene delivery technologies for cardiac applications
Gene Therapy (2012)
-
Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo
Gene Therapy (2011)